Clinical trials: Vocal Weakness(Post-BOTOX Injection)

Vocal Weakness(Post-BOTOX Injection)

Firdapse for Post-BOTOX Vocal Weakness

• Completed
• Age: 18 years and older
• Phase 2

Botox injections into the thyroarytenoid muscle are a predictable and effective treatment for SD, but typically result in transient symptoms of voice weakness and breathiness during the first 2-3 weeks after injection.

Trial name

NCT05123053

Testing

Amifampridine

Where

United States

Volunteers

18 people

Sponsor

Augusta University